This American Heart Association scientific statement provides comprehensive guidance on the evaluation and management of right-sided heart failure while identifying critical gaps in RV-specific therapies.
No takes yet. Share an insight, caveat, or question.
Right heart failure assessment is essential in PAH management; leaves open RV-specific therapies.
Konstam et al. (2018) studied this question. Chronic right-sided heart failure is associated with decreased exercise tolerance and is the principal cause of death in pulmonary arterial hypertension patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: